Spots Global Cancer Trial Database for lung
Every month we try and update this database with for lung cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Thoracoscopic Lung Cancer Staging With the Use of Intraoperative Ultrasound | NCT02218242 | Lung Cancer | Intraoperative ... | 18 Years - | University of Kentucky | |
| Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC) | NCT01069328 | Carcinoma, Non-... Lung Cancer | Nexavar (Sorafe... Nexavar (Sorafe... Bevacizumab Bevacizumab Bevacizumab Bevacizumab Paclitaxel Carboplatin | 18 Years - | Bayer | |
| A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer | NCT00558922 | Carcinoma, Non-... | AEG35156 | 18 Years - | Aegera Therapeutics | |
| Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer | NCT00522938 | Carcinoma, Non-... | CHR-2797 (tosed... erlotinib | 18 Years - | Chroma Therapeutics | |
| Safety and Efficacy of Cryoablation for Metastatic Lung Tumors | NCT01307501 | Metastatic Lung... | Cryoablation | 18 Years - | Boston Scientific Corporation | |
| A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer | NCT00558922 | Carcinoma, Non-... | AEG35156 | 18 Years - | Aegera Therapeutics | |
| MONET1-MOtesanib NSCLC Efficacy and Tolerability Study | NCT00460317 | Non-Small Cell ... | AMG 706 placebo paclitaxel carboplatin | 18 Years - | Amgen | |
| A New Pathway With BronchOscopic or Oesophageal Ultrasound for Lung Cancer Diagnosis and STaging (BOOST) | NCT00652769 | Bronchogenic Ca... | Endobronchial o... Bronchoscopy, C... | 18 Years - | University College London Hospitals | |
| A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors | NCT02605083 | Cancer | eFT508 | 18 Years - | Effector Therapeutics | |
| Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer | NCT00913705 | Non-Small-Cell ... | Neoadjuvant che... Adjuvant chemot... Surgery | 18 Years - | Spanish Lung Cancer Group | |
| Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC | NCT02059967 | Adenocarcinoma ... Large Cell Lung... Squamous Cell L... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | Paclitaxel image-guided ad... carboplatin | 18 Years - | Virginia Commonwealth University | |
| Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC) | NCT00356122 | Non-Small Cell ... | Docetaxel Oxaliplatin Bevacizumab | 18 Years - | Sanofi | |
| Dynamic PET CT as a Tool for Treatment Efficacy Monitoring in Lung Cancer | NCT02505685 | Lung Cancer | 18 Years - 95 Years | Rabin Medical Center | ||
| Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer | NCT01039311 | Lung Cancer | Optical Coheren... | 18 Years - | University of Oklahoma | |
| Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC | NCT02059967 | Adenocarcinoma ... Large Cell Lung... Squamous Cell L... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | Paclitaxel image-guided ad... carboplatin | 18 Years - | Virginia Commonwealth University | |
| A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer | NCT00558922 | Carcinoma, Non-... | AEG35156 | 18 Years - | Aegera Therapeutics | |
| Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC) | NCT02221739 | Non-small Cell ... | Ipilimumab Radiotherapy (I... | 18 Years - 99 Years | NYU Langone Health | |
| Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously | NCT01543672 | Lung Cancer Metastatic Lung... | Stereotactic Bo... Stereotactic Bo... | 18 Years - | The Netherlands Cancer Institute | |
| Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer | NCT00298896 | Carcinoma, Smal... Small Cell Lung... | SNS-595 | 18 Years - | Sunesis Pharmaceuticals | |
| Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients | NCT02879760 | Non-Small Cell ... | Ad-MAGEA3 MG1-MAGEA3 Pembrolizumab | 18 Years - | Turnstone Biologics, Corp. | |
| TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy | NCT02322281 | Non-small Cell ... | Rociletinib Pemetrexed or g... | 18 Years - | Clovis Oncology, Inc. | |
| A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers | NCT02583542 | Triple-Negative... Squamous Cell L... Non-squamous Ce... Non-squamous Ce... | AZD2014 AZD6244 | 18 Years - | Queen Mary University of London | |
| Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC) | NCT02221739 | Non-small Cell ... | Ipilimumab Radiotherapy (I... | 18 Years - 99 Years | NYU Langone Health | |
| EPIONE Guided Lung Evaluation | NCT05651867 | Lung Cancer | EPIONE device | 18 Years - | Quantum Surgical | |
| A Phase I Study of iPS Cell Generation From Patients With COPD | NCT01860898 | Thoracic Diseas... Respiratory Tra... Cancer of Lung Cancer of the L... Lung Cancer Lung Diseases, ... COPD Pulmonary Emphy... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Carcinoma, Smal... | Skin Biopsy | 18 Years - | Mayo Clinic | |
| Thoracoscopic Lung Cancer Staging With the Use of Intraoperative Ultrasound | NCT02218242 | Lung Cancer | Intraoperative ... | 18 Years - | University of Kentucky | |
| Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors | NCT01679470 | Primary or Meta... | AuroLase Therap... | 18 Years - | Nanospectra Biosciences, Inc. | |
| Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors | NCT01679470 | Primary or Meta... | AuroLase Therap... | 18 Years - | Nanospectra Biosciences, Inc. | |
| Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC) | NCT00356122 | Non-Small Cell ... | Docetaxel Oxaliplatin Bevacizumab | 18 Years - | Sanofi | |
| Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy | NCT00379665 | Carcinoma, Non-... | Cisplatin | 20 Years - 80 Years | Southwestern Regional Medical Center | |
| A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer | NCT02439450 | Non-small Cell ... | Viagenpumatucel... Nivolumab Pembrolizumab Pemetrexed | 18 Years - | Heat Biologics | |
| A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer | NCT01270386 | Non-Small-Cell ... | apatinib placebo | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases | NCT00366509 | Pulmonary Disea... Oropharyngeal D... Lymphangioleiom... Pulmonary Fibro... Asthma Sarcoidosis | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| A Phase I Study of iPS Cell Generation From Patients With COPD | NCT01860898 | Thoracic Diseas... Respiratory Tra... Cancer of Lung Cancer of the L... Lung Cancer Lung Diseases, ... COPD Pulmonary Emphy... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Carcinoma, Smal... | Skin Biopsy | 18 Years - | Mayo Clinic | |
| Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers | NCT00608452 | Lung Cancer Ovarian Cancer Breast Cancer Hodgkin's Disea... Neuroblastoma | Symptom Assessm... | - | Memorial Sloan Kettering Cancer Center | |
| Evaluation of Respiratory Motion-Corrected Cone-Beam CT in Radiation Treatment of Thoracic and Abdominal Cancers | NCT01213004 | Gastric Cancer Lung Cancer | respiration cor... respiration cor... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| EPIONE Guided Lung Evaluation | NCT05651867 | Lung Cancer | EPIONE device | 18 Years - | Quantum Surgical | |
| Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer | NCT00397293 | Small Cell Lung... | AT-101 topotecan | 18 Years - | Ascenta Therapeutics | |
| Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial | NCT04954625 | Lung Cancer | Autologous Bloo... Standard of Car... | 18 Years - | Rush University Medical Center | |
| Evaluation of Respiratory Motion-Corrected Cone-Beam CT in Radiation Treatment of Thoracic and Abdominal Cancers | NCT01213004 | Gastric Cancer Lung Cancer | respiration cor... respiration cor... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib | NCT00716456 | Lung Adenocarci... | erlotinib with ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Effects of Transcutaneous Nerve Electrostimulation (TENS) of Acupuncture Points on Pulmonary Function and Dyspnea Symptoms in Patients With Pulmonary Nodules | NCT04051398 | Lung Diseases Dyspnea Acupuncture | transcutaneous ... | 18 Years - | Hospital Santa Marcelina | |
| Heuristics, Algorithms and Machine Learning: Evaluation & Testing in Radiation Therapy | NCT04060706 | Cancer | Radical Image-G... | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| Endobronchial Ultrasound Guided Transbronchial Lung Biopsy With or Without Guide Sheath in Lung Tumors and the Analysis of Echoic Patterns of Lung Tumors and Mediastinal Lymph Nodes, and the Association Between Diagnostic Yield of Transbronchial Lung Biopsy and EBUS Echoic Features. | NCT00415337 | Lung Neoplasms | endobronchial u... | 18 Years - | Chang Gung Memorial Hospital | |
| Surgery Versus Stereotactic Body Radiation Therapy for Stage up to IA2 (T1a or T1b) Non-small Cell Lung Cancer | NCT03431415 | Non-small Cell ... Surgery Stereotactic Bo... | Anatomical Segm... Stereotactic Bo... | 18 Years - 75 Years | Institut universitaire de cardiologie et de pneumologie de Québec, University Laval | |
| Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers | NCT02423590 | Squamous Cell L... | Apatorsen (OGX-... Gemcitabine Carboplatin | 18 Years - | Queen Mary University of London | |
| Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer | NCT00374140 | Small Cell Lung... | RAD001 (everoli... | 18 Years - | University of Pittsburgh | |
| Blood, Hair and Lung Concentrations of Metals and Metalloids in Patients With Lung Cancer or Chronic Obstructive Pulmonary Disease | NCT01949181 | Lung Cancer Chronic Obstruc... Emphysema Lung Surgery | Lung surgery | 18 Years - 75 Years | Hopital Foch | |
| Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older | NCT00741039 | Breast Cancer Lung Cancer Prostate Cancer | inactivated inf... inactivated inf... | 65 Years - | Memorial Sloan Kettering Cancer Center | |
| A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies | NCT04678648 | Advanced Malign... RAS Mutation Lung Cancer Colon Cancer Glioblastoma Pancreatic Canc... | RSC-1255 Dose E... RSC-1255 Dose E... | 18 Years - | RasCal Therapeutics, Inc. | |
| Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis | NCT04076696 | Pulmonary Nodul... Pulmonary Nodul... | Scatter correct... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Utility of Endobronchial Ultrasound Guided Needle Biopsy in Early Stage Non- Small Cell Lung Cancer (NSCLC) | NCT00832715 | Lung Cancer | EBUS-TBNA | 18 Years - | M.D. Anderson Cancer Center | |
| Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer | NCT00232206 | Non-small-Cell ... | Neoadjuvant The... | 18 Years - | Providence Health & Services | |
| Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer | NCT03050060 | Metastatic Kidn... Recurrent Lung ... Stage IV Cutane... Stage IV Renal ... Stage IV Lung N... | Atezolizumab Hypofractionate... Laboratory Biom... Nelfinavir Mesy... Nivolumab Pembrolizumab | 18 Years - | University of Washington | |
| Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib | NCT05948462 | Lung Cancer Non-small Cell ... | Lorlatinib Cisplatin or Ca... Pemetrexed | 18 Years - | SCRI Development Innovations, LLC | |
| Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer | NCT00722605 | Esophageal Canc... Lung Cancer | cone-beam CT | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers | NCT02423590 | Squamous Cell L... | Apatorsen (OGX-... Gemcitabine Carboplatin | 18 Years - | Queen Mary University of London | |
| A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers | NCT02583542 | Triple-Negative... Squamous Cell L... Non-squamous Ce... Non-squamous Ce... | AZD2014 AZD6244 | 18 Years - | Queen Mary University of London | |
| TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy | NCT02322281 | Non-small Cell ... | Rociletinib Pemetrexed or g... | 18 Years - | Clovis Oncology, Inc. | |
| Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens | NCT01648166 | Lung Cancer | Environmental s... | 18 Years - | University of Kentucky | |
| Medico-economic Evaluation Comparing the Impact of the New Fixed-dose Nivolumab Regimen With the Old mg/kg Regimen in the Management of Patients With Metastatic Cancer | NCT05380336 | Metastatic Canc... | 18 Years - | Nantes University Hospital | ||
| Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer | NCT00522938 | Carcinoma, Non-... | CHR-2797 (tosed... erlotinib | 18 Years - | Chroma Therapeutics | |
| Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302） | NCT01924195 | Non-small Cell ... | Anlotinib Placebo capsule | 18 Years - 70 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver | NCT00986661 | Cancer Metastat... Hepatocellular ... Metastatic Mela... Metastatic Ocul... Metastatic Uvea... Metastatic Lung... Metastatic Colo... Metastatic Colo... Metastatic Brea... Metastatic Panc... | PV-10 (10% rose... | 18 Years - | Provectus Pharmaceuticals | |
| A New Pathway With BronchOscopic or Oesophageal Ultrasound for Lung Cancer Diagnosis and STaging (BOOST) | NCT00652769 | Bronchogenic Ca... | Endobronchial o... Bronchoscopy, C... | 18 Years - | University College London Hospitals | |
| Assess the Variability of Uni-Dimensional, Bi-Dimensional, and Volumetric CT Scan Measurement of Non-Small Cell Lung Cancer Tumors | NCT00579852 | Lung Cancer Non Small Cell | CT Scan | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT) | NCT01216371 | Renal Cell Carc... Pulmonary Metas... | Sunitinib Placebo | 18 Years - 75 Years | Association of Urologic Oncology (AUO) | |
| Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR | NCT00446225 | Non-Small Cell ... | Erlotinib Carboplatin Gemcitabin Docetaxel Cisplatin | 18 Years - | Spanish Lung Cancer Group | |
| Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC) | NCT00444015 | Non-Small-Cell ... | Erlotinib in co... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| 131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC) | NCT01124812 | Non Small Cell ... | 131I-L19SIP Rad... | 18 Years - | Philogen S.p.A. | |
| A Phase I Study of ECO-4601 in Patients With Advanced Cancer | NCT00338026 | Tumors Glioma Colorectal Canc... Lung Cancer Breast Cancer Ovarian Cancer Pancreatic Canc... Prostate Cancer | ECO-4601 | 18 Years - | Thallion Pharmaceuticals | |
| Pharmacogenomics IND EXEMPT SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms | NCT01064466 | Small Cell Lung... | ETOPOSIDE - Usu... ETOPOSIDE - Stu... | 22 Years - 75 Years | Medicine Invention Design, Inc | |
| A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma | NCT01439568 | Extensive Stage... | LY2510924 Carboplatin Etoposide | 18 Years - | Eli Lilly and Company | |
| A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose | NCT05142358 | Lung Cancer Left Sided Brea... | Continuous Posi... Deep inspirator... Free Breath | 18 Years - | Case Comprehensive Cancer Center | |
| Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib | NCT01189435 | Lung Cancer | erlotinib | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Health Communication in Families | NCT00597961 | Lung Cancer Melanoma Skin Cancer | 18 Years - | Memorial Sloan Kettering Cancer Center | ||
| Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously | NCT01543672 | Lung Cancer Metastatic Lung... | Stereotactic Bo... Stereotactic Bo... | 18 Years - | The Netherlands Cancer Institute | |
| A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer | NCT01770418 | Lung Neoplasms | Radiation with ... | 18 Years - | Proton Collaborative Group | |
| A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer | NCT01237678 | Small Cell Lung... | IMGN901 Carboplatin and... | 18 Years - | ImmunoGen, Inc. | |
| Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer | NCT01379976 | Non Small Cell ... | Acetylcarnitine Placebo | 18 Years - | Mario Negri Institute for Pharmacological Research |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
